Post-stroke mood disorders.
D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000627:therapeutic use; D001921:Brain / Q000503:physiopathology; D002395:Catecholamines / Q000502:physiology; D002561:Cerebrovascular Disorders / Q000150:complications* / Q000523:psychology; D003863:Depression / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D004292:Dominance, Cerebral / Q000502:physiology; D006801:Humans; D019964:Mood Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D011446:Prospective Studies; D011941:Receptors, Adrenergic / Q000502:physiology; D017983:Receptors, Catecholamine; D013997:Time Factors
D000929:Antidepressive Agents, Tricyclic; D002395:Catecholamines; D011941:Receptors, Adrenergic; D017983:Receptors, Catecholamine